Ilmu Pengetahuan Hayati: Modal Sekaligus Katalisator Kemajuan Indonesia

Naroeni, A., & B. Bela. 2021. Nurturing Responsible Future Generation of Scientists: Focus on Maintaining International Health Security Competency. Contemporary Developments and Perspectives in International Health Security 1: 1–14. 

Patra, S., & P. Praharaj, D. Panigrahi, B. Panda, C. Bhol, K. Mahapatra, S. R. Mishra, B. Behera, M. Jena, G. Sethi, S. Patil, S. Patra, & S. Bhutia. 2020. Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways. Molecular Biology Reports 47(6): 7209–7228.

Purwati, T., I. Brahmasari, N. Husda, Suhardi, & N. Aisyah. 2024. The Importance of Human Capital in the Indonesian Life Insurance Industry as a Competitive Advantage. Kurdish Studies 12(1): 614–630.

Rachmawaty, R. 2017. Ethical issues in action-oriented research in Indonesia. Nursing Ethics 24(6): 686–693. 

Rosadi, I., K. Moegni, V. Kharisma, A. Ansori, P. Ariesta, S. Dewi, A. Barlian, T. Fathimah, A. Zahra. 2024. Stem cell research in Indonesia from 2003 to 2022: A bibliometrics analysis. Journal of Pharmacy & Pharmacognosy Research 12: 557–572. 

Saffa, A. 2023. Indonesia’s Data-Driven Approach to Biodiversity. OpenGov. 1 hlm. https://opengovasia.com/2023/11/08/indonesias-data-driven-approach-to-biodiversity/, diakses 05 Juni 2024 pukul 13.27 WIB.

Sembiring, V. B. 2021. Human Capital Investment Development Strategy in Indonesia. Journal of Research in Business, Economics, and Education 3(2): 1715–1721.

Setyari, N. P. W., T. Widodo, & M. E. Purnawan. 2016. Comparative Advantage Dynamisn of Indonesian Export Products. The Journal of Developing Areas 50(5): 57–69.

The Biodiversity Finance Initiative (=BIOFIN). 2021. Indonesia. 1 hlm. https://www.biofin.org/indonesia, diakses 05 Juni 2024 pukul 12.46 WIB.

von Rintelen, K., E. Arida, & C. Häuser. 2017. A review of biodiversity-related issues and challenges in megadiverse Indonesia and other Southeast Asian countries. Research Ideas and Outcomes 3: 1–16.